| Literature DB >> 35202274 |
Vladimir B Mikheev1, Alexander Ivanov1.
Abstract
E-cigarette, or vaping, product use-associated lung injury (EVALI) outbreak was linked to vitamin E acetate (VEA) used as a solvent for tetrahydrocannabinol (THC). Several studies were conducted to assess the products of VEA (and THC/VEA mixtures) thermal degradation as a result of vaporizing/aerosolizing from a traditional type (coil-cotton wick) and ceramic type coil vape pens. The particle size distribution (PSD) of VEA aerosol and the temperature VEA and THC/VEA mixtures are heated to were also measured for a few types of traditional and ceramic vape pens. The current study assessed the PSD of the aerosol generated from THC, VEA, and a number of THC/VEA mixtures using a dab-type vape pen under two different temperature settings and two puffing flow rates. Thermal degradation of THC, VEA, and THC/VEA mixtures were also assessed, and coil temperature was measured. Results showed the dependence of the PSD upon the chemical content of the aerosolized mixture as well as upon the puffing flow rate. Minimal thermal degradation was observed. Flaws in the vape pen's design, which most likely affected results, were detected. The suitability of VEA, THC, and THC/VEA mixtures with certain types of vape pens was discussed.Entities:
Keywords: e-cigarette; particle size distribution; product use–associated lung injury (EVALI); tetrahydrocannabinol (THC); thermal degradation; vaping; vitamin E acetate (VEA)
Year: 2022 PMID: 35202274 PMCID: PMC8878975 DOI: 10.3390/toxics10020088
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Figure 1Kind Dream vape pen.
Figure 2Kind Dream heating element (left—coils, right—heated coils).
Figure 3IR temperature measurements (not all data shown, just two eight puffs sessions per test condition).
Summary of the DMS500 Data. Each data point shows average count median diameter (along with geometric standard deviation) across an eight puff session per testing condition (such as temperature set point, chemical content, and puffing flow rate). Each test was replicated three times.
| Temperature Set Point and Test# | VEA 20 mL/s CMD (GSD) nm | VEA 40 mL/s CMD (GSD) nm | 20THC/80VEA 20 mL/s CMD (GSD) nm | 20THC/80VEA 40 mL/s CMD (GSD) nm | 50THC/50VEA 20 mL/s CMD (GSD) nm | 50THC/50VEA 40 mL/s CMD (GSD) nm | 80THC/20VEA 20 mL/s CMD (GSD) nm | 80THC/20VEA 40 mL/s CMD (GSD) nm | THC 20 mL/s CMD (GSD) nm | THC 40 mL/s CMD (GSD) nm |
|---|---|---|---|---|---|---|---|---|---|---|
| 430 °F Test-1 | 111 (1.7) | 87 (1.7) | 160 (1.7) | 133 (1.6) | 171 (1.6) | 137 (1.7) | 186 (1.6) | 149 (1.7) | 190 (1.6) | 128 (1.6) |
| 430 °F Test-2 | 136 (1.7) | 89 (1.7) | 169 (1.6) | 138 (1.6) | 171 (1.6) | 141 (1.6) | 179 (1.6) | 148 (1.6) | 187 (1.7) | 142 (1.6) |
| 430 °F Test-3 | 139 (1.7) | 97 (1.7) | 135 (1.8) | 134 (1.6) | 177 (1.6) | 140 (1.6) | 185 (1.6) | 148 (1.7) | 183 (1.6) | 145 (1.6) |
| 350 °F Test-1 | 101 (1.8) | 79 (1.8) | 154 (1.7) | 128 (1.6) | 155 (1.7) | 126 (1.7) | 165 (1.7) | 136 (1.7) | 175 (1.6) | 137 (1.7) |
| 350 °F Test-2 | 111 (1.8) | 73 (1.8) | 177 (1.6) | 128 (1.6) | 167 (1.7) | 137 (1.7) | 168 (1.7) | 130 (1.7) | 180 (1.6) | 145 (1.6) |
| 350 °F Test-3 | 114 (1.8) | 80 (1.7) | 176 (1.6) | 129 (1.6) | 175 (1.7) | 141 (1.7) | 166 (1.7) | 137 (1.7) | 181 (1.6) | 140 (1.6) |
Summary of the DMS500 Data. Each data point shows the average particle number concentration across an eight puff session per testing condition (such as temperature set point, chemical content, and puffing flow rate). Each test was replicated three times.
| Temperature Set Point and Test# | VEA 20 mL/s PNC N/cc | VEA 40 mL/s PNC N/cc | 20THC/80VEA 20 mL/s PNC N/cc | 20THC/80VEA 40 mL/s PNC N/cc | 50THC/50VEA 20 mL/s PNC N/cc | 50THC/50VEA 40 mL/s PNC/cc | 80THC/20VEA 20 mL/s PNC N/cc | 80THC/20VEA 40 mL/s PNC N/cc | THC 20 mL/s PNC N/cc | THC 40 mL/s PNC N/cc |
|---|---|---|---|---|---|---|---|---|---|---|
| 430 °F Test-1 | 3.3E+07 | 7.8E+07 | 3.3E+07 | 7.2E+07 | 5.5E+07 | 9.1E+07 | 5.7E+07 | 8.1E+07 | 5.3E+07 | 9.1E+07 |
| 430 °F Test-2 | 3.3E+07 | 8.1E+07 | 4.5E+07 | 7.0E+07 | 5.6E+07 | 9.3E+07 | 5.2E+07 | 8.6E+07 | 4.9E+07 | 8.8E+07 |
| 430 °F Test-3 | 2.5E+07 | 8.5E+07 | 2.1E+07 | 6.8E+07 | 5.6E+07 | 9.1E+07 | 5.4E+07 | 8.1E+07 | 5.9E+07 | 8.7E+07 |
| 350 °F Test-1 | 1.8E+07 | 6.8E+07 | 2.7E+07 | 7.3E+07 | 3.7E+07 | 8.5E+07 | 4.8E+07 | 8.8E+07 | 5.0E+07 | 7.9E+07 |
| 350 °F Test-2 | 2.3E+07 | 6.5E+07 | 3.6E+07 | 7.6E+07 | 4.5E+07 | 8.7E+07 | 4.8E+07 | 8.6E+07 | 5.4E+07 | 9.0E+07 |
| 350 °F Test-3 | 2.0E+07 | 7.2E+07 | 4.0E+07 | 7.6E+07 | 4.6E+07 | 8.8E+07 | 4.9E+07 | 8.6E+07 | 5.7E+07 | 9.7E+07 |
Figure 4Examples of DMS500 spectrums for all testing conditions. Each plot shows one 5 s puff.
Figure 5Count Median Diameter vs. Chemical Composition at two temperature settings and two flow rates. Each test was replicated three times. Series number indicates test number.
Figure 6Particle Number Concentration vs. Chemical Composition at two temperature settings and two flow rates. Each test was replicated three times. Series number indicates test number.
MMAD measured by ELPI+ vs. MMAD estimated using Hatch–Choate equation from CMD and GSD measured by DMS500. Temperature set point 430 °F, flow rate 40 mL/s. Each test was replicated three times.
| Instrument | ELPI Measured MMAD, nm | DMS500 Estimated MMAD, nm | ELPI Measured MMAD, nm | DMS500 Estimated MMAD, nm |
|---|---|---|---|---|
| Chemical | 50THC/50VEA | 50THC/50VEA | THC | THC |
| Test-1 | 238 | 294 | 319 | 244 |
| Test-2 | 221 | 291 | 310 | 301 |
| Test-3 | 246 | 278 | 345 | 305 |